Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Treatment of Systemic Lupus Erythematosus With N-acetylcysteine
NCT00775476Phase 2Active, not recruiting
- Sponsor
- Upstate Medical University
- Start
- May 2022
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of acetylcysteine in systemic lupus erythematosus (SLE), sponsored by Upstate Medical University. Started May 2022; status: active, not recruiting.
02
Drugs
acetylcysteine
03
Conditions
systemic lupus erythematosus (SLE)
Beyond the preview
Go deeper on NCT00775476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00775476.